Concepedia

Author

Robert Lai

GlaxoSmithKline (United Kingdom)

Also Known As

R Y K Lai, R Y Lai, R. Lai, R.Y.K. Lai, Rachel Lai, Rilian Lai, Robert Lai, Robert Y. K. Lai, Robert Y. Lai, Robert Y.K. Lai

86

Publications

3.6K

Citations

27

H-Index

70

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)Eisai (United States)Imperial College LondonEisai (United Kingdom)Hammersmith Hospital
RL

About

Robert Lai is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, neuroscience, and neurology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

13

1.2K

2

Social Sciences

6

6

282

3

Health Sciences

5

5

343

4

Biochemistry

4

4

732

5

Natural Sciences

3

3

627

Robert Lai

×

35

Publications

3.4K

Citations

26

H-Index

YearCitations

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

Chad J. Swanson, Yong Zhang, Shobha Dhadda,

Alzheimer s Research & Therapy

2021

757

Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.

Claude M. Wischik, Patricia C. Edwards, Robert Lai,

Proceedings of the National Academy of Sciences

1996

532

Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody

Veronika Logovinsky, Andrew Satlin, Robert Lai,

Alzheimer s Research & Therapy

2016

278

The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans

Boris A. Chizh, M. O'Donnell, Antonella Napolitano,

Pain

2007

244

Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury

Praveen Anand, Ravikiran Shenoy, Joanne Palmer,

European Journal of Pain

2011

166

Chronic Oral Gabapentin Reduces Elements of Central Sensitization in Human Experimental Hyperalgesia

Hanne Gottrup, Gitte Irene Juhl, Anders D. Kristensen,

Anesthesiology

2004

137

A simultaneous ERP/fMRI investigation of the P300 aging effect

Redmond G O’Connell, Joshua H. Balsters, Sophia M. Kilcullen,

Neurobiology of Aging

2012

122

A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [18F]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's Disease

Sofia Tzimopoulou, Vincent J. Cunningham, Thomas E. Nichols,

Journal of Alzheimer s Disease

2011

108

Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18 F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls

Davangere P. Devanand, Arthur Mikhno, Gregory H. Pelton,

Journal of Geriatric Psychiatry and Neurology

2010

107

Enhanced Sensitivity of Insulin-resistant Adipocytes to Vanadate Is Associated with Oxidative Stress and Decreased Reduction of Vanadate (+5) to Vanadyl (+4)

Bing Lu, David Ennis, Robert Lai,

Journal of Biological Chemistry

2001

105

Page 1